Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of E-2814 in Alzheimer's disease/dementia.

Trial Profile

Phase I study of E-2814 in Alzheimer's disease/dementia.

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2018

At a glance

  • Drugs E 2814 (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Dec 2018 According to an Eisai Co Ltd media release, this trial is expected to be initiated in early 2019.
    • 06 Dec 2018 According to an Eisai Co Ltd media release, the company and University College London (UCL) have commenced preparations for this study. The study expects to commence within fiscal 2018.
    • 19 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top